TNFSF10 and glioblastoma: Given application of the TRAIL-based therapy in pre-clinical trials and obstacle of TRAIL resistance for the therapeutic benefit in GBM, we wondered to know that if there is a functional link between miR-137 and TRAIL sensitivity and to further investigate a proper synergistic effect of miR-137 and TRAIL in the treatment of GBM.